Introduction
The first committed step in the biosynthesis of riboflavin is the removal of carbon atom 8 from GTP [1] . Since it has been shown that the ribose moiety of the precursor is directly converted to the ribityl moiety of the final product, the biosynthesis must involve rearrangement and reduction of the side chain as well as deamination in position 2 of the pyrimidine ring [2j. In agreement with this 
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hypothesis, the biosynthetic pathway shown in Fig. 1 was proposed on the basis of further biochemical and genetic studies with mutants of Saccharomyces cerevisiae [2] [3] [4] [5] . However, it remained unknown whether the intermediates are phosphoric acid esters or not. Attempts to deaminate unphosphorylated 2.5-diamino-6-hydroxy-4-ribitylaminopyrimidine by cell extract from S. cerevisiae proved unsuccessful [6] .
Recently Burrows and Brown reported the conversion of GTP to 6,7-dimethyl-8-ribityllumazine by the subsequent action of (i) cyclohydrolyse II, (ii) a deaminase, and (iii) a reductase from Escherichia coli followed by treatment with phosphatase and diacet}d [7] . On this basis, the authors suggested that deamination precedes reduction of the side chain, in contrast to the pathway in Fig. 1 . No direct evidence for the structure of the intermediates proposed by the authors has been reported.
In this paper we describe the enzymatic deamination of 2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate by cell extracts from Candida guilliermondii and Saccharomyces cerevisiae. These data agree with the pathway outlined in Fig. 1 . 
Chemicals
2,5-Diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate was prepared from 2-amino-6-hydroxy-5-nitro-4-ribitylaminopyrimidine [8] by unequivocal chemical synthesis (details to be published separately). Alkaline phosphatase was purchased from Boehringer, Mannheim, and Florisil from Sigma.
Organisms
The strains oiS. cerevisiae have been described [9] . Candida guilliermondii ATCC 9058 was obtained from the American Type Culture Collection. Lacto-bacillus casei ATCC 7469 was a gift of Dr. Bernhard Mailänder, Pfizer Inc.
Culture media and growth of cells
The medium used for S. cerevisiae contained, per liter: 10 g yeast extract (Difco), 10 g peptone (Difco), 20 g glucose. Riboflavin (20 mg/1) was added as required. Cells were grown in flasks without aeration at 30 °C. Candida guilliermondii was grown in Burkholder's medium [10] on a rotary shaker at 30 °C. Bacillus subtilis mutant H 94 was grown as described [11] . Cells were harvested by centrifugation and washed with 0.1 M NaCl. They were stored at -20 °C.
Preparation of cell extract
Frozen cell paste was passed through an X-press. The cell paste was thawed, diluted with 0.1 M phosphate buffer pH 7.0, and centrifuged. The supernatant was dialyzed overnight against 0.1 M phosphate pH 7.0. Cell extract of B. subtilis H 94 was prepared as described [11] ; the cell extract was treated with degased charcoal (10 mg/ml), centrifuged, and dialyzed against 0.1 M phosphate pH 7.0.
Enzyme assays
Riboflavin synthase: The assay for riboflavin synthase has been described [11] .
Deaminase: Assay mixtures contained 0.1 M phosphate pH 7.0, 5 mM MgCl2, 5 mM dithioerythritol, 1 mM 2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate (freshly prepared), and protein (3 to 15 mg/ml). The total volume was 0.2 ml. Blanks contained no substrate but otherwise were prepared and treated identically throughout. The assay mixtures and blanks were incubated at 37 °C for 40 min. Subsequently, 0.1 ml of a solution containing 70 mM glycine" buffer pH 10.5, 0.7 mM MgCl2, 0.07 mM ZnCl2, 60 mM diacetyl, alkaline phosphatase (11 units/ml), and charcoal-treated crude extract from B. subtilis equivalent to 700 units of riboflavin synthase/ml was added. The samples were again incubated for 60 min at 37 °C. Subsequently, 0.5 ml of an ammonium sulfate solution saturated at room temperature was added to precipitate protein. The samples were centrifuged at 20,000 g for 20 minutes.
Aliquots of the supernatant (10 to 100 /d) were added to tubes containing 5 ml of riboflavin assay medium (Difco; 24g/l). The tubes were sterilized for 10 min at 121 °C. A standard curve using known aliquots of riboflavin (0 to 140 ng/tube) was prepared with each experiment.
The tubes were inoculated with a washed suspension of L. casei ATCC 7469 and incubated for 2 days at 37 °C. Growth was recorded turbidimetrically.
Miscellaneous methods
Protein was determined by the biuret method. Thin layer chromatography was performed with Kieselgel 60 plates (Merck AG) and a solvent system containing butanol/acetic acid/water (50:15:35).
Results and Discussion
In initial experiments, 2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate was incubated with crude cell extract from C. guilliermondii ATCC 9058. The mixture was treated with diacetyl and phosphatase and passed through a column of Florisil (lxl cm). The column was washed with water, and fluorescent material was eluted with 50% acetone. The solution was brought to dryness under reduced pressure. The residue was dissolved in 0.2 ml of deionized water. Analysis by thin layer chromatography showed that substantial amounts of 6,7-dimethyl-8-ribityllumazine had been formed.
In quantitative studies, 6,7-dimethyl-8-ribityllumazine formed by the subsequent action of cell extract and diacetyl was converted to riboflavin by the action of riboflavin synthase. The riboflavin thus formed was determined by microbiological assay using L. casei ATCC 7469. In assays with cell extract from C. guilliermondii ATCC 9058, up to 24% of the substrate was converted to riboflavin. Quantitative conversion of the substrate to riboflavin is not to be expected since no attempts were made to prevent the autoxidation of the highly reactive pyrimidine substrate.
Studies with cell extracts from the wild strain and various riboflavin deficient mutants of S. cerevisiae are shown in Table I . Wild type and mutants of genotype rib 5 and rib 7 show similar deaminase activities. However, the deaminase is absent in all rib 2 mutants studied. Rib 2 mutants have been shown previous^ to excrete the dephosphorylated substrate of the deaminase, 2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine [3] . On this basis, Bacher and coworkers concluded that rib 2 is the structural gene for deaminase [2, 5] . This is confirmed by the enzymatic studies reported in this paper.
The possibility that the true biosynthetic intermediate may be a phosphoric acid ester of 2,5-diamino-6-hydroxy-4-ribit3daminopyrimidine has been discussed earlier [2, 3] . Our studies show conclusively that the substrate of the deaminase is the 5'-phosphate of2,5-diamino-6-hvdroxy-4-ribitylaminopyrimidine. The unphosphorylated compound is not deaminated by cell extract from S. cerevisiae [6J. We have as yet no evidence whether the product of the deaminase is 5-amino-2,6-dihydroxy-4-ribitylaminopyrimidine or its 5'-phosphate. The available data are consistent with both hypotheses. The question whether the product of the deaminase retains the 5'-phosphoric acid residue is currently under study. The experiments are hampered by the relatively high level of endogeneous phosphatase in the cell extracts.
Since the termination of these experiments, Hollander and Brown [12] reported on the enzymatic conversion of the 14 C-labeled product of cyclohydrolase II (tentatively identified as 2,5-diamino-6-hydroxy-4-ribosylaminopyrimidine-5'-phosphate) by cell extracts from Ashby a gossypii. The authors report the formation of 6,7-dimethyl-8-ribityllumazine and 2-amino-4-hydroxy-6,7-dimethyl-8-ribitylpteridine in low yield. However, direct chemical evidence on the structure of the supposed enzyme substrates and products has not been reported.
In experiments with the genetically derepressed B. subtilis mutant H 94, we were unable to detect any deaminase activity in our standard assay. This agrees with the hypothesis proposed by Burrows and Brown [7] that the biosynthesis of riboflavin may follow different pathways in bacteria and in yeasts.
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